(Billable Hours is Reuters' weekly report on lawyers and money. Please send tips or suggestions to ...

Medicare no longer covers Wegovy specifically for weight loss purposes, though coverage may still be available when ...

Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...

Novo Nordisk will sell a less expensive one-month supply of Wegovy for patients who previously took compounded versions of ...

Retail investor sentiment around Hims & Hers Health remained negative over the weekend after the telehealth firm confirmed it ...

A new clinical trial has revealed that tirzepatide (Zepbound) surpasses semaglutide (Wegovy) in promoting weight loss among ...

A new study has compared Wegovy and Zepbound head-to-head in their ability to treat obesity. People taking Eli Lilly’s ...

Novo Nordisk said on Thursday it would offer temporary discounts to cash-paying customers for its weight-loss drug Wegovy, in ...

Dozens of Ozempic, Mounjaro and Wegovy users are reporting drug-induced hepatitis, prompting medical experts to call for ...

Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, ...

Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly.

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...